Introduction: Coronavirus disease 2019 (COVID-19) an infectious disease was first identified in December 2019 in Wuhan,
China, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). It was considered by the World Health Organization
(WHO) as a pandemic. Oropharyngeal manifestations like mucositis, glossitis, pharyngitis, tonsillar enlargement associated with
COVID19 show inconsistency in their presentations. Hence the study aims at the early identification and better management of the
Aims and Objectives This study is to detect, analyze and to determine the prevalence of the different oropharyngeal
manifestations reported in COVID19 positive patients
Materials: Patients who are diagnosed with COVID 19 using RT-PCR method, were assessed for symptoms and signs of
oropharyngeal manifestations using standard questionnaires.
Method: Cross sectional study.
Results: Out of 486 COVID positive patients’ males outnumbered female patients. The highest number of oropharyngeal
manifestations was seen in patients in the age group of 51-65 years (42%). Least age and highest age of the patient encountered in
this study was 19 years and 78 years, respectively. Dry cough (37.8%) was the most common symptom followed by pharyngodynia
(24.2%) with the least common being painful ulcers in mouth (4.9%). Among 486 COVID positive patients’ pharyngeal
erythema(46.9%) was the most common manifestation followed by glossitis,(29.2%) and buccal mucositis(19.1%). Aphthous ulcer
(4.9%) was the least common manifestation. In our study nearly 45.8% (223 in number) of patients had history of diabetes followed
by hypertension in 38.7% (188 numbers) as the co morbidity found in COVID positive patients. Neoplasia was the least common co
Conclusion: Oropharyngeal manifestations for COVID-19 are not common as fever and cough. But a universal questionnaire
using well-defined COVID-19 manifestations is needed to make the COVID-19 data precisely defined, complete and homogenous
and to differentiate from the etiology other than COVID 19.